Evidence map›Paper›PMID 31499530›Full record

ArticleInvestigative ophthalmology & visual science2019

Patterns and Intensities of Near-Infrared and Short-Wavelength Fundus Autofluorescence in Choroideremia Probands and Carriers.

Maarjaliis Paavo, Jose R L Carvalho, Winston Lee, Jesse D Sengillo, Stephen H Tsang, Janet R Sparrow

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Choroideremia: Toward Regulatory Approval of Retinal Gene Therapy.Cold Spring Harbor perspectives in medicine · 2023
    Article
  8. Choroideremia Carriers: Dark-Adapted Perimetry and Retinal Structures.Investigative ophthalmology & visual science · 2022
    Article
  9. Structural evaluation in inherited retinal diseases.The British journal of ophthalmology · 2021
    Review
  10. Article
  11. Fundus autofluorescence imaging.Progress in retinal and eye research · 2021
    Review
  12. Article
  13. Retinal Manifestations of Mitochondrial Oxidative Phosphorylation Disorders.Investigative ophthalmology & visual science · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Multimodal Imaging in Choroideremia.Advances in experimental medicine and biology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 3 countries.

Maarjaliis PaavoDepartment of Ophthalmology Columbia University Medical Center, New York, New York, United States.
Jose R L CarvalhoDepartment of Ophthalmology Columbia University Medical Center, New York, New York, United States.
Winston LeeDepartment of Ophthalmology Columbia University Medical Center, New York, New York, United States.
Jesse D SengilloDepartment of Ophthalmology Columbia University Medical Center, New York, New York, United States.
Stephen H TsangDepartment of Ophthalmology Columbia University Medical Center, New York, New York, United States.
Janet R SparrowDepartment of Ophthalmology Columbia University Medical Center, New York, New York, United States.
Columbia University Irving Medical Center · US

Funding

Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Quantitative Fundus Autofluorescence in Retinal DisordersR01EY024091 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SPARROW, JANET RUTHE · 2014 to 2022
$3.4M
NEI NIH HHS P30 EY019007NEI NIH HHS R01 EY024091
6 · The paper itself

Abstract

Purpose: To ascertain cellular constituents within islands of preserved retina in choroideremia (CHM) by multimodal imaging. Methods: CHM probands (16) and female carriers (9) of CHM were studied. Near-infrared autofluorescence (NIR-AF; 787-nm excitation; emission, >830 nm), short-wavelength autofluorescence (SW-AF; 488-nm excitation, 500- to 680-nm emission), and spectral-domain optical coherence tomography (SD-OCT) images were acquired with a confocal scanning laser ophthalmoscope. SW-AF intensities were measured by quantitative fundus autofluorescence (qAF), and NIR-AF intensity profiles were analyzed. Retinal thicknesses and visual acuity were measured. Results: In 19 of 31 eyes of affected males, islands of preserved NIR-AF signal were also visible as fluorescence signal in SW-AF images. Notable in 12 eyes were areas of speckled SW-AF that was hypoautofluorescent in the NIR-AF image. Islands of preserved NIR-AF and SW-AF signal were often associated with the presence of visible but thinned outer nuclear layer and discontinuous interdigitation zone, ellipsoid zone, and external limiting membrane. NIR-AF profiles revealed that even in areas of preserved retina, the NIR-AF signal from retinal pigment epithelium (RPE) melanin is greatly reduced. qAF was reduced overall. The fundus of carriers was characterized by a mosaicism in which patches of reduced NIR-AF colocalized with reduced SW-AF. Conclusions: In CHM-affected males, the presence of RPE was indicated by an NIR-AF signal and the absence of hypertransmission of OCT signal into the choroid. RPE preservation was associated with better visual acuity. In carriers, patches of reduced SW-AF colocalized with decreased NIR-AF and qAF was severely reduced.

Indexed as

AdolescentAdultAgedChildChoroideremiaFemaleFundus OculiHeterozygoteHumansInfrared RaysMaleMiddle AgedMultimodal ImagingOptical ImagingRetinaRetinal Pigment Epithelium

Identifiers

PMID31499530
PMCPMC6735265
OpenAlexW2972314213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.